Description of the subject of the contract 1. The subject of the contract is the supply of pharmaceutical products, according to 26 tasks, in accordance with the quantities and requirements set out in Annex 3 to these specifications ‘Assortment and price form’, (a) partial tenders may be submitted for individual tasks; b) partial selection of tenders is reserved, where a part is a particular task; tenders not containing the full scope of the subject-matter of the contract as set out in Annex 3 to the specifications for individual tasks shall be rejected; The Contractor may submit tenders for one, several or all of the tasks. 2. Additional conditions relating to the subject-matter of the contract: a) the unit price of a medicine included in the list of reimbursed medicines may not be higher than it results from the provision of Article 9(2) of the Act of 12 May 2011 on the reimbursement of medicines, foodstuffs intended for particular nutritional uses and medical devices, b) the Ordering Party agrees to change the size of packages (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the provisions indicated in the SPC), c) Any own names of products and standards and attestations referred to in the specification serve to determine the desired standard of performance and properties and requirements assumed for the subject of the contract. In this case, the Employer allows the use of equivalent solutions, provided that it meets all the requirements of the Employer. d) Quality requirements for medicinal products are set out in the Pharmaceutical Law Act of 6 September 2001 (Journal of Laws of 2025, item 750 i.e.) which in Art. Paragraph 1(1) provides that it lays down, inter alia, the rules and procedures for authorising medicinal products, taking into account, in particular, the requirements relating to the quality, efficacy and safety of their use.' In addition, the Regulation of the Minister of Health of 9 November 2015 on the requirements of Good Manufacturing Practice (Dz. Journal of Laws 2015, item 1979 as amended) sets out in detail the requirements for ensuring the quality of the medicinal product. In the proceedings in question, the quality standard for medicinal products was defined by the Ordering Party by providing in the description of the subject-matter of the contract, which includes, inter alia: composition, form and route of administration and unit of measurement. 3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products OTHER. Foreign Entity 1. If the contractor has its registered office or place of residence outside the Republic of Poland, instead of: 1) information from the National Criminal Register referred to in point. 10.1/1 SWZ (§ 2 para. 1 point 1 of the Regulation on personal evidence) - submits information from an appropriate register, such as a court register, or, in the absence of such a register, another equivalent document issued by a competent judicial or administrative authority of the country in which the economic operator is established or resident, to the extent referred to in point. 10.1/1 SWZ (§ 2 para. 1(1) of the Regulation on personal evidence); 2) the certificate referred to in point. 10.1/3 SWZ (§ 2 para. 1 point 4 of the Regulation on personal means of proof), a certificate or other document confirming that the contractor is not in arrears with the payment of social or health insurance contributions referred to in point. 10.1/4 SWZ (§ 2 para. 1 point 5 of the Regulation on subjective means of proof), or a copy or information from the National Court Register or from the Central Register and Information on Economic Activity, referred to in point. 10.1/5 SWZ (§ 2 para. 1 point 6 of the Regulation on personal means of proof) - submits a document or documents issued in the country in which the contractor has its registered office or place of residence, confirming respectively that: has not infringed obligations relating to the payment of taxes, levies or social security or health insurance contributions, (b) has not been wound up, has not been declared bankrupt, has not had its assets administered by a liquidator or by a court, has not entered into an arrangement with creditors, has not had its business activity suspended or is not in any other situation of that kind arising from a similar procedure provided for in the law of the place where that procedure is opened. 2. The document referred to in point. 10.2/1/1 SWZ, should be issued not earlier than 6 months before its submission. The documents referred to in 10.2/1/2 SWZ should be issued not earlier than 3 months before their submission. 3. If the documents referred to in point 10.2/1 are not issued in the country where the economic operator has its registered office or place of residence or the person to whom the document relates, or if these documents do not relate to all the cases referred to in Article 108(1)(b) and (c) EUTMR, the documents referred to in point 10.2/1 shall not be issued in the country where the economic operator has its registered office or place of residence or the person to whom the document relates. 1 points 1, 2 and 4, Article 109 para. Points 1, 2(a) and (b) and 3 of the Act shall be replaced, respectively, in whole or in part, by a document containing, respectively, a declaration by the economic operator, indicating the person or persons authorised to represent it, or a declaration made on oath by the person to whom the document was to be applied, or, if the economic operator has its registered office or place of residence or the person to whom the document was to be applied has its registered office or place of residence, there are no provisions on a declaration on oath made before a judicial or administrative authority, a notary, a professional or economic self-regulatory body competent for the registered office or place of residence of the economic operator or the place of residence of the person to whom the document was to be applied. Point 10.2/2 shall apply. GDPR 1. The exercise by the data subject of the right to rectification or supplementation referred to in Article 16 of Regulation 2016/679 may not result in a change in the outcome of the procurement procedure or in a change in the provisions of the public procurement contract to an extent contrary to the law.
Text automatically translated in your browsing language
